Thomas H C, Farci P, Shein R, Karayiannis P, Smedile A, Caruso L, Gerin J
Prog Clin Biol Res. 1987;234:277-90.
Lymphoblastoid interferon inhibited hepatitis delta virus (HDV) replication in four out of five HDV carriers with chronic active liver disease. Serum HDV-RNA was undetectable in three patients, but in one of these evidence of continuing intrahepatic HDV replication was present on biopsy one year after treatment. In the four cases which showed total or partial inhibition of HDV replication, there was a transient increase in transaminases during treatment, and in three this was followed by improvement. These effects lasted for longer than one year. The lysis of hepatocytes occurring on exposure to interferon may be related to the induction of 2-5A oligosynthetase which, in the presence of the dsRNA of HDV, activates endonucleases which destroy the rRNA of the infected cells.
淋巴母细胞干扰素抑制了五分之四患有慢性活动性肝病的丁型肝炎病毒(HDV)携带者体内的HDV复制。在三名患者中检测不到血清HDV-RNA,但其中一名患者在治疗一年后的活检中显示仍有肝内HDV持续复制的证据。在HDV复制受到完全或部分抑制的四例患者中,治疗期间转氨酶短暂升高,其中三例随后病情有所改善。这些效果持续了一年多。接触干扰素时发生的肝细胞溶解可能与2-5A寡聚合成酶的诱导有关,在HDV的双链RNA存在的情况下,该酶激活核酸内切酶,从而破坏被感染细胞的rRNA。